These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36226640)

  • 1. Mismatch negativity and clinical trajectories in psychotic disorders: Five-year stability and predictive utility.
    Donaldson KR; Jonas K; Foti D; Larsen EM; Mohanty A; Kotov R
    Psychol Med; 2023 Sep; 53(12):5818-5828. PubMed ID: 36226640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of mismatch negativity with psychotic symptoms and functioning transdiagnostically across psychotic disorders.
    Donaldson KR; Novak KD; Foti D; Marder M; Perlman G; Kotov R; Mohanty A
    J Abnorm Psychol; 2020 Aug; 129(6):570-580. PubMed ID: 32757601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mismatch negativity amplitude in first-degree relatives of individuals with psychotic disorders: Links with cognition and schizotypy.
    Donaldson KR; Larsen EM; Jonas K; Tramazzo S; Perlman G; Foti D; Mohanty A; Kotov R
    Schizophr Res; 2021 Dec; 238():161-169. PubMed ID: 34695710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding the missing-stimulus mismatch negativity (MMN) in early psychosis: altered MMN to violations of an auditory gestalt.
    Rudolph ED; Ells EM; Campbell DJ; Abriel SC; Tibbo PG; Salisbury DF; Fisher DJ
    Schizophr Res; 2015 Aug; 166(1-3):158-63. PubMed ID: 26072323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal relationships between mismatch negativity, cognitive performance, and real-world functioning in early psychosis.
    Higgins A; Lewandowski KE; Liukasemsarn S; Hall MH
    Schizophr Res; 2021 Feb; 228():385-393. PubMed ID: 33549980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of mismatch negativity (MMN) in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness.
    Fisher DJ; Labelle A; Knott VJ
    Schizophr Res; 2012 Aug; 139(1-3):237-45. PubMed ID: 22727705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of complex mismatch negativity (cMMN) elicited by a two-tone pattern paradigm in early-phase psychosis.
    Ells EML; Rudolph ED; Sculthorpe-Petley L; Abriel SC; Campbell DJ; Tibbo PG; Fisher DJ
    Biol Psychol; 2018 May; 135():128-135. PubMed ID: 29596955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity.
    Perez VB; Woods SW; Roach BJ; Ford JM; McGlashan TH; Srihari VH; Mathalon DH
    Biol Psychiatry; 2014 Mar; 75(6):459-69. PubMed ID: 24050720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic sensory information processing abnormalities across the illness course of schizophrenia.
    Jahshan C; Cadenhead KS; Rissling AJ; Kirihara K; Braff DL; Light GA
    Psychol Med; 2012 Jan; 42(1):85-97. PubMed ID: 21740622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis.
    Hamilton HK; Roach BJ; Bachman PM; Belger A; Carrión RE; Duncan E; Johannesen JK; Light GA; Niznikiewicz MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Cannon TD; Mathalon DH
    JAMA Psychiatry; 2022 Aug; 79(8):780-789. PubMed ID: 35675082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced duration mismatch negativity in adolescents with psychotic symptoms: further evidence for mismatch negativity as a possible biomarker for vulnerability to psychosis.
    Murphy JR; Rawdon C; Kelleher I; Twomey D; Markey PS; Cannon M; Roche RA
    BMC Psychiatry; 2013 Feb; 13():45. PubMed ID: 23375130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMN and P3a Elicited by a Novelty Oddball Paradigm Are Not Reduced in Early-Phase Psychosis.
    Riel H; Rudolph E; MacPhee C; Tibbo PG; Fisher DJ
    Neuropsychobiology; 2022; 81(6):506-515. PubMed ID: 36380625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal Frequency Mismatch Negativity in Early Psychosis Outpatient Subjects.
    Del Re EC; Maekawa T; Mesholam-Gately RI; Wojcik J; Seidman LJ; McCarley RW; Niznikiewicz MA
    Clin EEG Neurosci; 2020 Jul; 51(4):207-214. PubMed ID: 31826666
    [No Abstract]   [Full Text] [Related]  

  • 15. Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia.
    Koshiyama D; Miyakoshi M; Thomas ML; Joshi YB; Molina JL; Tanaka-Koshiyama K; Sprock J; Braff DL; Swerdlow NR; Light GA
    Schizophr Res; 2021 Feb; 228():280-287. PubMed ID: 33493776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurophysiological biomarkers support bipolar-spectrum disorders within psychosis cluster.
    Kaur M; Battisti RA; Lagopoulos J; Ward PB; Hickie IB; Hermens DF
    J Psychiatry Neurosci; 2012 Sep; 37(5):313-21. PubMed ID: 22469054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.
    Light GA; Braff DL
    Arch Gen Psychiatry; 2005 Feb; 62(2):127-36. PubMed ID: 15699289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced duration mismatch negativity elicited by the multi-feature 'optimal' paradigm in early-phase psychosis.
    Riel H; Rudolph ED; MacPhee C; Tibbo PG; Fisher DJ
    Biol Psychol; 2023 May; 180():108570. PubMed ID: 37116608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of mismatch negativity (MMN) and novelty P300 in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness.
    Fisher DJ; Smith DM; Labelle A; Knott VJ
    Biol Psychol; 2014 Jul; 100():43-9. PubMed ID: 24865523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mismatch negativity (MMN) and sensory auditory processing in children aged 9-12 years presenting with putative antecedents of schizophrenia.
    Bruggemann JM; Stockill HV; Lenroot RK; Laurens KR
    Int J Psychophysiol; 2013 Sep; 89(3):374-80. PubMed ID: 23707338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.